Press Releases

August 23, 2013 Lupin Receives FDA Approval for Generic Rifadin® Capsules

August 7, 2013 Lupin Expands Branded Play Announces Acquisition of Exclusive US Rights to Alinia® for Oral Suspension

August 7, 2013 Strong Margins, Robust Profitability Quarter I Results, FY 2013-14 EBITDA up 44%, Net profit up 43%

August 1, 2013 Lupin receives FDA Approval for Generic Ranexa® Extended-release Tablets

July 31, 2013 Lupin Receives Tentative FDA Approvals for Generic Nuvigil® Tablets and Generic Oracea® Capsules

July 18, 2013 MSD and Lupin announce Strategic Partnership to Co-market MSD’s 23-valent Pneumococcal polysaccharide vaccine (PPV) for Indian market

May 8, 2013 Lupin announces Executive Board Leadership Changes

May 8, 2013 Record Sales and Profits

April 26, 2013 Lupin receives FDA approval for its Oral Contraceptive Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets